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http://stemcellres.com/content/5/6/125RESEARCH Open Access17beta-estradiol promotes the odonto/osteogenic
differentiation of stem cells from apical papilla via
mitogen-activated protein kinase pathway
Yao Li1,2, Ming Yan3, Zilu Wang2, Yangyu Zheng2, Junjun Li2, Shu Ma2, Genxia Liu2 and Jinhua Yu2,3*Abstract
Introduction: Estrogen plays an important role in the osteogenic differentiation of mesenchymal stem cells, while
stem cells from apical papilla (SCAP) can contribute to the formation of dentin/bone-like tissues. To date, the effects
of estrogen on the differentiation of SCAP remain unclear.
Methods: SCAP was isolated and treated with 10-7 M 17beta-estradiol (E2). The odonto/osteogenic potency and
the involvement of mitogen-activated protein kinase (MAPK) signaling pathway were subsequently investigated by
using methyl-thiazolyl-tetrazolium (MTT) assay, and other methods.
Results: MTT and flow cytometry results demonstrated that E2 treatment had no effect on the proliferation of
SCAP in vitro, while alkaline phosphatase (ALP) assay and alizarin red staining showed that E2 can significantly
promote ALP activity and mineralization ability in SCAP. Real-time reverse transcription polymerase chain reaction
(RT-PCR) and western blot assay revealed that the odonto/osteogenic markers (ALP, DMP1/DMP1, DSPP/DSP, RUNX2/
RUNX2, OSX/OSX and OCN/OCN) were significantly upregulated in E2-treated SCAP. In addition, the expression of
phosphor-p38 and phosphor-JNK in these stem cells was enhanced by E2 treatment, as was the expression of the
nuclear downstream transcription factors including phosphor-Sp1, phosphor-Elk-1, phosphor-c-Jun and phosphor-c-Fos,
indicating the activation of MAPK signaling pathway during the odonto/osteogenic differentiation of E2-treated SCAP.
Conversely, the differentiation of E2-treated SCAP was inhibited in the presence of MAPK specific inhibitors.
Conclusions: The ondonto/osteogenic differentiation of SCAP is enhanced by 10-7 M 17beta-estradiol via the activation
of MAPK signaling pathway.Introduction
When the dental pulp of a young tooth with open apex
is infected due to caries or trauma, dentists often try to take
measures (for example, apexification and apexogenesis) to
preserve the root development and maturation [1]. During
the process, a series of factors are involved in the growth
of the root, for instance, stem cells from apical papilla
(SCAP), which still exist after the formation of the root
and can survive the infection [2,3]. SCAP have a high
proliferation rate and possess osteo/dentinogenic and
adipogenic potentials [4,5]. When transplanted into* Correspondence: yujinhua@njmu.edu.cn
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unless otherwise stated.immunocompromised mice, SCAP can form a typical
dentin-pulp-like complex and generate bone-like tissues
containing osteoblast-like cells [4-6]. Moreover, the com-
bination of SCAP and periodontal ligament stem cells
(PDLSCs) can produce dentin and cementum with colla-
gen fibers anchored into the cementum after transplant-
ation in vivo, which represents an approach to biological
root engineering [7]. Thus, such a biological root support-
ing a porcelain crown can restore a missing tooth instead
of bridges and removable dentures. Huang et al. [2] have
suggested that SCAP play an important role in root for-
mation. Many factors can affect the proliferation and
odonto/osteogenic differentiation of SCAP, including cul-
ture medium, cell phenotype, medicaments, growth factors,
hormones, morphogens, and so on [8-11] that demonstrate
the importance of the extrinsic microenvironment to
SCAP when applied in tissue engineering.his is an Open Access article distributed under the terms of the Creative
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ment, reproduction and maintenance of a diverse range
of mammalian tissues. Estrogen is known as one of the
important hormones for sex maturation and bone me-
tabolism [12]. Previous research has revealed a close re-
lationship between estrogen deficiency and osteoporosis
that occurs in postmenopausal women, and older men
as well, leading to decreased bone mineral density and
even bone fracture [13]. It has also been demonstrated
that periodontal diseases are related to estrogen defi-
ciency which causes impaired osteogenic differentiation
of PDLSCs [14]. Furthermore, an in vivo study has
shown that the differentiation ability of dental pulp stem
cells (DPSCs) was downregulated in estrogen deficient
rats [12]. Recent studies have suggested that exogenous
estrogen can enhance the proliferation and differentiation
of bone marrow mesenchymal stem cells (BMMSCs),
PDLSCs and DPSCs [8,15,16]. To date, the effects of
estrogen on SCAP remain unclear.
In this study, we investigated the influence of estrogen
on the proliferation and odonto/osteogenic differentiation
of SCAP in vitro. SCAP was isolated from extracted third
molars and exposed to 17beta-estradiol (E2) [17]. Then,
the proliferation, differentiation and involvement of the
MAPK signaling pathway in E2-treated SCAP were deter-
mined. Our findings suggest that E2 can enhance the
odonto/osteogenic differentiation of SCAP via the MAPK
pathway.
Methods
Cell isolation and culture
Impacted non-carious third molars (n = 20) were collected
from young patients (17- to 20-years old) in the Oral
Surgery Department of Jiangsu Provincial Stomatological
Hospital. This study was approved by the Ethical Committee
of the Stomatological School of Nanjing Medical University
(Reference #200900128), and consent from patients was
obtained. The apical papillae were carefully separated from
the immature roots, minced and digested in a solution
containing 3 mg/ml collagenase type I (Sigma, St. Louis,
MO, USA) and 4 mg/ml dispase (Sigma) for 30 minutes at
37°C. Single cell suspensions were obtained and cells from
different patients were mixed. Isolated cells were cultured in
alpha minimum essential medium (α-MEM, Gibco, Life
Technologies, Grand Island, NY, USA) supplemented with
10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA),
100 U/mL penicillin and 100 mg/mL streptomycin at 37°C
in 5% CO2. 17beta-estradiol (E2, Ehrenstorfer Gmbh,
Augsburg, Germany) was dissolved in absolute ethyl alcohol
at 10-3 M and stored at −20°C in the dark. In the subsequent
experiments, cells were cultured in α-MEM containing E2
(E2 group) or 0.01% (v/v) ethyl alcohol as control (control
group). The culture medium was changed every two days.
JNK and p38 specific inhibitors SP600125 (Sigma-Aldrich,St. Louis, MO, USA) and SB203580 (Sigma-Aldrich) were
dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) at
100 mM and 20 mM, respectively and stored at −20°C in
the dark. They were diluted to 20 μM when added to the
culture media. Cells at passages two to four were used for
the following experiments.
Cell identification
To determine the origin of the obtained mesenchymal stem
cells, isolated cells were immunostained with antibody
against STRO-1 (1:200, Novus Biologicals, Littleton, CO,
USA) and their surface markers were measured by flow
cytometry. Cells were harvested and incubated with
fluorochrome-conjugated rabbit anti-human antibodies:
CD34-FITC, CD45-PerCP, CD90-PE, CD105-APC, CD146-
APC, CD73-PE (Miltenyi, Bergisch Gladbach, Germany)
for 20 minutes at room temperature in the dark. Stained
cells were washed twice with 0.01 M phosphate buffer
solution (PBS) and analyzed by BD FACSCalibur (BD
Biosciences, San Jose, CA, USA).
In vivo transplantation
The animal experiments were approved by the Ethical
Committee of the Stomatological School of Nanjing Medical
University. SCAP (1 × 106) was collected as a pellet in a
sterile tube and seeded gently onto absorbable gelatin
sponges (AGS, Nanjing Pharmaceuticals, Nanjing, China),
which served as carriers. Then, cell pellets were transplanted
into the renal capsules of immunodeficient female rats. After
in vivo culture for eight weeks, the retrieved implants (n = 6)
were fixed in 4% polyoxymethylene, decalcified and proc-
essed for hematoxylin and eosin (H & E) staining.
Immunohistochemistry and immunocytochemistry
Immunohistochemical and immunocytochemical analyses
of human tissues or human SCAP were performed by the
streptavidin-biotin complex method using the primary
antibodies (STRO-1, 1:200, Santa Cruz, Dallas, TX, USA;
ER-α, 1:100, Abcam, Cambridge, UK) according to the
manufacturers’ recommended protocols [18,19]. The reac-
tion products were developed in 3, 3′-diaminobenzidine
solution with hydrogen peroxide and counterstained with
hematoxylin.
MTT assay
SCAP were seeded into 96-well plates (Nunc, Thermo
Scientific, Waltham, MA, USA) at a density of 2 × 103 cells/
well for 24 hours and starved in a serum-free medium for
another 24 hours. Then the medium was changed to
complete medium containing E2. At different time points
(days 0, 1, 3, 5, 7, 9 and 11), the cells were treated with
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl-2, 5-
tetrazoliumbromide) solution (5 mg/ml; Sigma-Aldrich)
and incubated at 37°C for four hours. Then, the solution
Table 1 Sense and antisense primers for real-time reverse
transcription polymerase chain reaction
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absorbance (OD value) was measured at 490 nm with an
automatic enzyme-linked immunosorbent assay reader
(ELx800, BioTek Instruments Inc., Grand Island, NY,
USA). The experiment was repeated three times and
MTT results are expressed as the mean ± SD.
Colony forming assay
SCAP in the control group and the E2 group were seeded
into six-well plates (Nunc, USA) at a density of 1 × 102
cells/well for two weeks. Then, the cells were fixed with
4% paraformaldehyde (PFA), stained with crystal violet
(Beyotime, Shanghai, China) and photographed. The
colonies were visualized under an inverted microscope
(Olympus, Hamburg, Germany). Aggregations of more
than 50 cells were defined as colonies and then counted.
The experiment was repeated three times.
Flow cytometry for cell cycle
SCAP were plated into 6-cm culture dishes (Nunc, USA),
cultured in α-MEM supplemented with 10% FBS until 60%
to 70% confluence, and then serum-starved for 24 hours.
E2 was added to the culture media of the experimental
groups. After three days of incubation, the cells were
harvested and fixed with 75% ice-cold ethanol at 4°C for
30 minutes in the dark. DNA content was measured by
FAC-Scan flow cytometer (BD Biosciences, San Jose, CA,
USA). Cell cycle fractions (G0/G1, S, and G2/M phases)
were determined by flow cytometry (FCM). The experiment
was repeated three times.
Alkaline phosphatase (ALP) activity assay and alizarin red
staining
SCAP in the control group and the E2 group were
seeded into 96-well plates (Nunc, USA) at a density of
2 × 103 cells/well or 24-well plates (Nunc, USA) at a
density of 1 × 104 cells/well and cultured in routine
media or mineralization-inducing media (MM) containing
α-MEM, 10% FBS, 100 U/ml penicillin, 100 μg/ml strepto-
mycin, 100 μM ascorbic acid, 2 mM 2-glycerophosphate
and 10 nM dexamethasone. Alkaline phosphatase (ALP)
activity assay was performed as previously reported [20]
by using an ALP activity kit (Sigma-Aldrich) and normal-
ized to total protein content in the cells at days 5 and 7.
At day 14, alizarin red staining was carried out as
described before [21] and images were acquired using
a scanner. Then, nodule staining was destained by 10%
cetylpyridinium chloride (CPC) in 10 mM sodium phos-
phate for 30 minutes at room temperature. The calcium
concentration was determined by measuring the absorb-
ance at 526 nm with a universal microplate reader (BioTek
Instruments). This experiment was performed in triplicate
and the results are presented as the mean ± SD.Real-time reverse transcription polymerase chain reaction
(real-time RT-PCR)
Total cell RNA was isolated using TRIzol reagent (Invitrogen,
New York, NY, USA) according to the manufacturer’s
protocol. The concentration and purity of the RNA sam-
ples were determined by the absorbance of RNA at 230,
260 and 280 nm, respectively. The mRNA was reverse-
transcribed into cDNA by using a PrimeScript RT Master
Mix kit (TaKaRa Biotechnology, Dalian, China). Real-time
RT-PCR was performed using a SYBR1 Premix Ex Taq™
kit (TaKaRa, Otsu, Japan) and ABI 7300 real-time PCR
system. Real-time RT-PCR reaction conditions were: 95°C
for 30 seconds; followed by 40 cycles of 95°C for 5 seconds,
60°C for 31 seconds. Primers used in this experiment are
listed in Table 1. GAPDH was used as an internal control
and the expression of osteo/odontoblast-associated genes
(ALP, DSPP, DMP1, RUNX2, OSX and OCN) was measured
by the 2-ΔΔCt method as previously reported. Data are given
as the mean ± SD of three independent experiments.
Western blot analysis
To explore the effects of E2 on odonto/osteogenic differ-
entiation of SCAP, SCAP in the control group and the
E2 group were cultured for three and seven days, re-
spectively, and then collected. For the evaluation of the
MAPK signaling pathway, SCAP was seeded on 6-cm
dishes. After 24 hours of incubation, cells were serum-
starved for another 24 hours before exposure to E2 for
30 minutes, 60 minutes and 90 minutes, respectively.
Cells in different groups were washed twice with cold
PBS and lysed in radioimmunoprecipitation assay (RIPA)
lysis buffer (Beyotime) containing 1 mM phenylmethyl-
sulfonyl fluoride (PMSF). Cell debris was eliminated by
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protein and nucleoprotein were obtained with a Keygen Kit
(Keygen Biotech, Nanjing, China). Protein concentration
was measured by the Bradford protein assay. A total of
30 μg protein per lane was loaded onto a 10% SDS-PAGE
gel for electrophoresis and then electroblotted (Bio-Rad,
Hercules, CA, USA) onto 0.22 μm polyvinylidene fluoride
(PVDF) membrane (Millipore, Bedford, MA, USA) at
300 mA for one hour. Membranes were blocked with block-
ing solution (5% non-fat dried skimmed milk powder,
0.01 M PBS, 0.1% Tween-20 (PBST)) at room temperature
for two hours, and subsequently incubated with primary
antibodies (DMP1, 1:1000, Abcam; DSP, 1:1000, Santa Cruz;
RUNX2, 1:1000, Abcam; OSX, 1:1000, Abcam; OCN,
1:1000, Millipore, Billerica, MA, USA; ERK1/2, 1:1000, Bio-
world , St. Louis Park, MN, USA; phosphor-ERK1/2, 1:1000,
Bioworld; JNK1/2/3, 1:1000, Bioworld; phosphor-JNK1/2/3,
1:1000, Bioworld; p38, 1:1000, Bioworld; phosphor-p38,
1:1000, Bioworld; Elk-1, 1:1000, Cell Signaling, Danvers,
MA, USA; phosphor-Elk-1, 1:1000, Cell Signaling; Sp1,
1:1000, Cell Signaling; phosphor-Sp1, 1:1000, Cell Signaling;
c-Jun, 1:1000, Cell Signaling; phosphor-c-Jun, 1:1000, Cell
Signaling; c-Fos, 1:1000, Cell Signaling; phosphor-c-Fos,
1:1000, Cell Signaling; ER-α, 1:1000, Abcam; β-ACTIN,
1:1000, Bioworld; H3, 1:1000, Bioworld) overnight at 4°C.
β-ACTIN and H3 were, respectively, used as the internal
controls. Finally, the membranes were washed with PBST
for 10 minutes × 3 followed by incubation in secondary
antibodies (1:10,000, Boster, Wuhan, China) for one hour at
37°C, and visualized with ImageQuant LAS4000 system (GE
Healthcare, Pittsburgh, PA, USA). The results were quanti-
fied with ImageJ software (National Institutes of Health,
Bethesda, MD, USA). The experiment was repeated three
times.
Immunofluorescence
E2 treated and untreated SCAP were, respectively, cultured
on glass coverslips. After three days culture, cells were
washed twice with PBS, fixed in 4% polyoxymethylene for
30 minutes at room temperature, permeabilized with 0.5%
Tween 20 for 10 minutes and then blocked with goat
serum for 30 minutes at 37°C. After that, cells were
incubated with primary antibodies (DSP, 1:50, Santa Cruz;
RUNX2, 1:100, Abcam; OCN, 1:100, Millipore) overnight
at 4°C. The fluorescence-labeled secondary antibody was
added and incubated for one hour at room temperature.
Nuclei were stained by 4,6-diamidino-2-phenylindole
(DAPI; 1:1,000; Invitrogen) for two minutes. Immunofluor-
escence was visualized under a microscope.
Statistics
The quantitative results were expressed as the mean ± SD.
Independent samples t test, Chi-square test, one-way ana-
lysis of variance (ANOVA) and Tukey’s multiple comparisontest were performed with SPSS 17.0 software. P values <0.05
were considered to be statistically significant.
Results
Identification of SCAP
The isolated cells presented the typical fibroblast- or
spindle-like morphology and stained positively for STRO-1
(a mesenchymal stem cell marker, Figure 1A). FCM find-
ings revealed that these cells were positive for CD73,
CD146, CD90 and CD105, but negative for CD45 and
CD34, indicating that these cells are mesenchymal stem
cells (Figure 1C). Moreover, in vivo transplantation of such
purified cells demonstrated that these cells formed the
typical dentin-pulp-like complex containing the structures of
dental pulp, odontoblasts, predentin and dentin (Figure 1D).
Columnar odontoblasts with polarized nuclei aligned
regularly along the predentin (Figure 1E).
Dose-dependent effects of E2 on SCAP
SCAP were treated with different concentrations of E2
(10-9 M, 10-7 M, and 10-5 M) to detect the dose-dependent
effects of E2. MTT results at day 5 demonstrated that
10-9 M and 10-7 M E2 did not affect the proliferation of
SCAP while 10-5 M E2 significantly inhibited cell prolifera-
tion (Figure 2A; P <0.05). ALP activity assay at day 5 re-
vealed that 10-9 M E2 had no effect on the differentiation
of SCAP while 10-7 M E2 significantly promoted cell differ-
entiation (Figure 2B; P <0.01). However, the differentiation
ability significantly decreased in 10-5 M E2-treated SCAP
(Figure 2B; P <0.01). Thus, 10-7 M was selected as the opti-
mal concentration of E2 used in the following experiments.
Effects of E2 on morphology and proliferation of SCAP
SCAP were cultured in α-MEM containing 10-7 M E2
(E2 group) or 0.01% (v/v) ethyl alcohol as control (control
group). Both the control group and the E2 group pre-
sented a spindle-like morphology and shared almost the
same appearance (Figure 2C-F). FCM analysis showed
no distinct difference (P >0.05) in the proliferation index
(PI = G2M+ S) between the control group (6.67%) and the
E2 group (7.37%) (Figure 2G-I). MTT assay on 11 con-
secutive days also presented no significant difference
(P >0.05) between the two groups (Figure 2J), and nei-
ther did the results of a colony forming assay between
the control group and the E2 group (Figure 2K and L).
E2 had no significant effect on the morphology and
proliferation of SCAP.
Effects of E2 on odonto/osteogenic differentiation of SCAP
Immunocytochemical analysis of SCAP showed that the
staining of STRO-1 in the cytoplasma of E2-treated
SCAP was weaker than that in control group, suggesting
the downregulation of STRO-1 following the differenti-
ation of E2-treated SCAP (Figure 3A and B).
Figure 1 Identification of SCAP. (A) Isolated SCAP were stained positively for STRO-1 with typical fibroblast- or spindle-like morphology. (B) PBS
served as a negative control. (C) Isolated SCAP were positive for CD73, CD146, CD90 and CD105, but negative for CD45 and CD34 by flow
cytometry. (D) In vivo transplantation of SCAP pellets formed the typical dentin-pulp-like complex containing dental pulp, odontoblasts, predentin
and dentin. (E) A higher magnification of (D). DP, dental pulp; OB, odontoblast; D, dentin; PD, predentin. Scale bars: A, B and D = 100 μm,
E = 25 μm. SCAP, stem cells from apical papilla.
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without E2. At day 5, E2 exerted no influence on ALP
activity of SCAP in routine media, while ALP activity
was noticeably upregulated by E2 in MM (Figure 3C;
P <0.01). At day 7, both E2-treated groups exhibited
a significant increase in ALP activity of SCAP (Figure 3C;P <0.01). Moreover, alizarin red staining and quantitative
calcium measurement demonstrated that SCAP treated
with E2 produced more calcium nodules after 14 days
of incubation (Figure 3D and E; P <0.05). When ob-
served under an inverted microscope, the calcium nod-
ules formed in routine media were fewer and smaller,
Figure 2 Effects of E2 on morphology and proliferation of SCAP. (A) MTT assay at day 5 for E2-treated SCAP at different concentrations
(concentration screening). (B) ALP activity in E2-treated SCAP at different concentrations (concentration screening). (C) The morphology of SCAP
in the control group. (D) A higher magnification of (C). (E) The morphology of SCAP in the E2 group. (F) A higher magnification of (E). (G) Flow
cytometry analysis of control SCAP. (H) Flow cytometry analysis of E2-treated SCAP. (I) Average proliferation indexes (PI = S + G2M) in the control
group (6.67%) and the E2 group (7.37%, P >0.05). (J) Growth curves for control and E2-treated SCAP. (K) Colony forming assay for control and
E2-treated SCAP. (L) Average number of colonies formed in the control group (14) and the E2 group (16.5, P >0.05). Values are given as the
mean ± SD, n = 3. *P <0.05, **P <0.01. ALP, alkaline phosphatase; E2, 17beta-estradiol; MTT, methyl-thiazolyl-tetrazolium; SCAP, stem cells from
apical papilla; SD, standard deviation.
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nodules in MM. Moreover, the shape of the calcium
nodules in the MM + E2 group was more regular than
in other groups (Figure 3F-I).
Real-time RT-PCR showed that the odonto/osteogenic
genes (ALP, DMP1, DSPP, RUNX2, OSX and OCN) were
remarkably enhanced in E2-treated SCAP. In particular,
the expression of ALP, DMP1, DSPP, RUNX2 and OSX
increased from day 3 to day 7 at a significant extent
(Figure 3J and K; P <0.01), while the expression of OCN
rose at a similar level at day 3 and day 7 (Figure 3J and
K; P <0.05). Western blot findings showed that the ex-
pression of the odonto/osteogenic proteins (DMP1, DSP,
RUNX2, OSX and OCN) was significantly upregulated
in E2-treated SCAP at day 3 and 7, in comparison with cells
in the control group (Figure 3L-O; P <0.01 or P <0.05).
The immunofluorescent results demonstrated that
RUNX2 was expressed in the nuclei while OCN and
DSP were mainly located in the cytoplasm. They were
all enhanced following E2 treatment, indicating the
promotion of odonto/osteogenic differentiation in SCAP
by E2 (Figure 4).Involvement of the MAPK pathway during differentiation
of E2-treated SCAP
To determine the potential involvement of the MAPK
signaling pathway in the E2-mediated differentiation of
SCAP, we investigated the ER-α level as well as the expres-
sion of MAPK-related proteins and downstream transcrip-
tion factors. SCAP showed positive staining for ER-α
(Figure 5A) and the expression of ER-α was notably en-
hanced following E2 treatment (Figure 5D and E; P <0.01).
However, E2 treatment did not affect the expression of
total ERK, JNK and p38. The level of phosphor-ERK al-
most did not change with time, whereas phosphorylation
of JNK and p38 gradually upregulated from 0 to 90 mi-
nutes following E2 treatment (Figure 5F-I; P <0.01). For
the nuclear downstream transcription factors, the levels of
total Sp1, Elk-1, c-Jun and c-Fos did not change in a time-
dependent manner. Phosphorylation of Sp1 was signifi-
cantly enhanced at 60 minutes and remained at a high
level at 90 minutes after E2 treatment (Figure 5J and K;
P <0.01). Phosphorylation of Elk-1 gradually increased
from 0 to 60 minutes but was noticeably downregulated
at 90 minutes by E2 treatment (Figure 5J and L; P <0.01).
Figure 3 Odonto/osteogenic differentiation was enhanced in E2-treated SCAP. (A) Immunocytochemical staining of STRO-1 in the control
group. (B) Immunocytochemical staining of STRO-1 in the E2 group. Scale bars = 100 μm. (C) ALP activity in the control group, E2 group,
mineralization-inducing group (MM) and MM + E2 group at day 5 and 7, respectively. Values are presented as the mean ± SD, n = 3. **P <0.01.
(D) Alizarin red staining for the control group, E2 group, MM group and MM + E2 group at day 14. (E) Quantitative analysis of calcium content in
the different groups. Values are the mean ± SD, n = 3. *P <0.05. (F-I) Calcium nodules in the different groups under the inverted microscope. Scale
bars = 100 μm. (J) Real-time RT-PCR analysis for the expression of ALP, DMP1, DSPP, RUNX2, OSX and OCN in control and E2-treated SCAP at day 3.
Values are the mean ± SD, n = 3. **2-ΔΔCt >2, P <0.01; *1 < 2-ΔΔCt <2, P <0.01. (K) Real-time RT-PCR analyses for the expression of ALP, DMP1, DSPP,
RUNX2, OSX and OCN in control and E2-treated SCAP at day 7. Values are the mean ± SD, n = 3. **2-ΔΔCt >2, P <0.01; *1 < 2-ΔΔCt <2, P <0.01. (L)
Western blot assay for the odonto/osteogenic proteins (DMP1, DSP, RUNX2, OSX and OCN) in control and E2-treated SCAP at day 3. (M) Quantitative
analysis of western blot results at day 3. Values are the mean ± SD, n = 3. **P <0.01. (N) Western blot assay of the odonto/osteogenic proteins in control
and E2-treated SCAP at day 7. (O) Quantitative analysis of western blot results at day 7. Values are the mean ± SD, n = 3. *P <0.05, **P <0.01.
ALP, alkaline phosphatase; E2, 17beta estradiol; SCAP, stem cells from apical papilla; SD, standard deviation.
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upregulated at 30 minutes and then gradually decreased
from 60 to 90 minutes following E2 treatment (Figure 5J
and M; P <0.01). Moreover, the phosphor-c-Fos level rose
from 0 to 90 minutes after treatment with E2 (Figure 5J
and N; P <0.01 or P <0.05).
To further determine the role of the MAPK signaling
pathway during the differentiation of E2-treated SCAP,
SP600125 and SB203580 (specific inhibitors of JNK and
p38) were used at a concentration of 20 μM to suppress
the activity of JNK and p38 signaling for one hour prior
to E2 treatment. The ALP activity of SCAP at day 5 was
remarkably inhibited by SP600125 and SB203580 (Figure 6A;
P <0.01). Furthermore, odonto/osteogenic proteins (DMP1,
DSP, RUNX2, OSX and OCN) were significantly downreg-
ulated in the E2 + SP600125 group and the E2 + SB203580
group, in comparison with the E2 group at day 3 and day
7 (Figure 6B-E; P <0.01 or P <0.05).
Discussion
Diverse research has revealed that estrogen can exert
some effects on bone and mesenchymal stem cells
(MSCs). Exogenous estrogen can not only increasebone mineral density and promote bone formation, but
also has beneficial effects on the proliferation and differen-
tiation of BMMSCs [16,22-25]. Even adipose tissue-derived
stem cells (ADSCs) can possess osteogenic differenti-
ation potential after estrogen stimulation, with greater
nodule formation and mineral deposition [26]. Estrogen
has also been reported to increase ALP activity, the expres-
sion of osteocalcin and mineralized nodules in PDLSCs
[27]. Our previous study revealed that exogenous estrogen
at physiological concentrations can enhance the odonto/
osteogenic differentiation of DPSCs [8].
In the present study, a higher concentration of E2
(10-5 M) significantly inhibited the proliferation of SCAP
while 10-7 and 10-9 M E2 had no effect on cell growth, in-
dicating that there may exist a dose-dependent manner of
E2 in regulating the proliferation of SCAP. To evaluate
the effects of E2 on the differentiation of SCAP under
similar conditions, impacts of E2 on cell proliferation
should be excluded. E2 at 10-7 M did not have any nega-
tive influence on cell morphology and cell proliferation as
indicated by MTT, FCM and colony forming assay, while
this concentration of E2 can trigger the differentiation
of SCAP. Thus, 10-7 M E2 was selected as the optimal
Figure 4 Immunolocalization of odonto/osteogenic markers in SCAP. (A-C) Immunofluorescent staining of RUNX2 in control SCAP.
(D-F) Immunofluorescent staining of RUNX2 in E2-treated SCAP. (G-I) Immunofluorescent staining of OCN in control SCAP. (J-L) Immunofluorescent
staining of OCN in E2-treated SCAP. (M-O) Immunofluorescent staining of DSP in control SCAP. (P-R) Immunofluorescent staining of DSP in E2-treated
SCAP. Scale bars = 100 μm. E2, 17beta estradiol; SCAP, stem cells from apical papilla.
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in vitro.
After E2 treatment, ALP activity, mineralization capacity
and odonto/osteogenic markers (ALP, DMP1/DMP1,
DSPP/DSP, RUNX2/RUNX2, OSX/OSX and OCN/OCN)
in SCAP were significantly upregulated. DSP protein and
DSPP mRNA are tooth-specific markers that contribute to
the formation of dentin and they have been reported to be
expressed only in secretory odontoblasts [28-30]. DSP
protein and DSPP mRNA have been identified as late-
stage markers of odontoblasts, the expression of which in-
dicates the mature differentiation of odontoblasts [31].
DMP1 is expressed in odontoblasts and secretes matrixproteins to form dentin, which contributes to later denti-
nogenesis during postnatal development [32]. Moreover,
research has suggested that DSPP is a downstream ef-
fector molecule of DMP1 which is probably regulated by
DMP1 during dentinogenesis [32,33]. ALP, RUNX2 and
OSX are early-stage markers of osteoblastic differentiation
while OCN is related to the late-stage osteoblastic differ-
entiation [24,34-36]. ALP is expressed early in the devel-
oping osteoblast, during the phase of matrix deposition
and is downregulated in calcifying osteoblasts [26].
RUNX2 is a crucial factor in osteoblast and odonto-
blast differentiation, regulating the expression of a var-
iety of bone-/tooth-related genes [29]. Previous studies
Figure 5 Activation of the MAPK signaling pathway in E2-mediated odonto/osteogenic differentiation of SCAP. (A) SCAP were stained
positively for ER-α. (B) Human breast carcinoma tissue served as a positive control. (C) PBS served as a negative control. Scale bars = 100 μm.
(D) ER-α level detection by western blot analysis in control and E2-treated SCAP. (E) Quantitative analysis of the expression of ER-α in control and
E2-treated SCAP. Values are mean ± SD, n = 3. **P <0.01. (F) The expression of MAPK related proteins (ERK, p-ERK, JNK, p-JNK, p38 and p-p38) by
western blot. β-ACTIN was used as the internal control. (G) The ratio changes of p-ERK/ERK intensity in E2-treated SCAP. (H) The ratio changes of
p-JNK/JNK intensity in E2-treated SCAP. (I) The ratio changes of p-p38/p38 intensity in E2-treated SCAP. (J) The expression of nuclear downstream
transcription factors (Sp1, p-Sp1, Elk-1, p-Elk-1, c-Jun, p-c-Jun, c-Fos and p-c-Fos) by western blot analysis. (K) The ratio changes of p-Sp1/Sp1
intensity in E2-treated SCAP. (L) The ratio changes of p-Elk-1/Elk-1 intensity in E2-treated SCAP. (M) The ratio changes of p-c-Jun/c-Jun intensity in
E2-treated SCAP. (N) The ratio changes of p-c-Fos/c-Fos intensity in E2-treated SCAP. Values are the mean ± SD, n = 3. *P <0.05, **P <0.01. ERα,
estrogen receptor α; E2, 17beta estradiol; MAPK, mitogen-activated protein kinase; SCAP, stem cells from apical papilla; SD, standard deviation.
Li et al. Stem Cell Research & Therapy 2014, 5:125 Page 9 of 12
http://stemcellres.com/content/5/6/125have revealed that Runx2-deficient mice have impaired
tooth formation while RUNX2 overexpression induces
new bone generation [37,38]. OSX is a downstream gene
of RUNX2, which plays an important role in osteogenic
differentiation and bone formation and is expressed in
functional odonto/osteoblasts [8,39]. OCN is considered
a marker for bone formation in the late stage, which has
a close relationship with bone maturation [40]. In the
present study, both early-stage and late-stage odonto/
osteogenic markers were upregulated, implying the long-
term effects of E2 on the differentiation of SCAP.
Previous research has revealed that estrogen stimulates
sequential differentiation of osteoblasts and increases
calcium deposition in cultured BMSSCs in an estrogen
receptor (ER)-dependent manner [41]. As the classic ster-
oid receptors, ERs (including ER-α and ER-β) generallymediate the biological responses to estrogen via genomic
and non-genomic effects [42]. It is suggested that the con-
centration of ERs is an important determinant of cellular
responsiveness to estrogen [43-45]. Moreover, an in-
creased level of ER has been detected during the osteo-
blastic differentiation of rat calvarial osteoblasts [46].
In this study, E2-treated SCAP showed higher expression
of ER-α and enhanced odonto/osteogenic potential. Re-
cent studies have suggested that estrogen’s effects on
various tissues may be mediated by different cell signal-
ing pathways [47]. E2 can regulate the bioactivity of ER-
α-positive endometrial cancer cells on the basis of the
MAPK signaling pathway. MAPK are an important fam-
ily of protein kinases involved in transmitting signals
from the cell membrane to the nucleus [48]. There are
three well-characterized subfamilies of MAPK, that is,
Figure 6 SP600125 and SB203580 inhibited odonto/osteogenic differentiation of E2-treated SCAP. (A) ALP activity at day 5 in different
groups (control group, E2 group, E2 + SP600125 group and E2 + SB203580 group). (B) Odonto/osteogenic protein expression (DMP1, DSP, RUNX2,
OSX and OCN) in different groups at day 3. (C) Quantitative analysis of odonto/osteogenic proteins (DMP1, DSP, RUNX2, OSX and OCN) in different
groups at day 3. (D) Western blot analysis for odonto/osteogenic proteins (DMP1, DSP, RUNX2, OSX and OCN) in different groups at day 7.
(E) Quantitative analysis of odonto/osteogenic proteins (DMP1, DSP, RUNX2, OSX and OCN) in different groups at day 7. Values are the mean ± SD,
n = 3. *P <0.05, **P <0.01. ALP, alkaline phosphatase; E2, 17beta-estradiol; SCAP, stem cells from apical papilla; SD, standard deviation.
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terminal kinase (JNK) and p38 MAPK. MAPK signaling
regulates cell proliferation, differentiation, survival and
apoptosis in a variety of cells. In this study, E2 has some
effects on the expression of phosphor-JNK and phosphor-
p38 but did not change the level of phosphor-ERK, indi-
cating the activation of JNK signaling and p38 MAPK sig-
naling. In addition, the decreased level of mineralization
and differentiation in E2-treated SCAP co-cultured with
SP600125 or SB203580 confirmed the potential functions
of JNK and p38 MAPK signaling. Therefore, it can be con-
cluded that E2 regulates the odonto/osteogenic differenti-
ation of SCAP via activation of the JNK and p38 MAPK
pathways.
To further evaluate the MAPK signaling involved in
E2-mediated differentiation of SCAP, the nuclear down-
stream transcription factors of MAPK were investigated
by western blot analysis. The phosphorylation of all re-
lated transcription factors (phosphor-Sp1, phosphor-Elk-1,
phosphor-c-Jun and phosphor-c-Fos) can be detected in a
time-dependent manner, indicating the activation of these
downstream factors by E2 stimulation. E2 action occurs
via the classical genomic and non-genomic ways [49]. The
genomic pathway is a slow progress mediated through
ERs by binding to an estrogen-responsive element (ERE)in the promotor region of different target genes [50],
whereas the non-genomic action of E2 mediated by a
membrane-associated receptor (mER) is very fast [51].
It is suggested that liganded ERs can not only bind dir-
ectly to ERE to regulate the transcription of genes, but
also are tethered to DNA by interacting with other tran-
scription factors, such as Sp1 and activating protein-1
(AP-1) to influence the gene expression, which means
E2 can induce the expression of related genes through
ER/Sp1 and ER/AP-1 complexes [52,53]. In addition, E2
can trigger rapid effects including activation of a sequen-
tial series of kinases and phosphatases through mem-
branes, such as the MAPK signaling pathway, and then
induce the phosphorylation of ERs in the nuclei to regu-
late transcription [42,54]. As is known, when activated
by upstream factors, JNK can stimulate the phosphoryl-
ation of c-Jun, its major downstream substrate, which
can interact with c-Fos to form a complex, leading to
enhanced AP-1 and upregulated transcription activity
[55]. In addition, the activation of p38 MAPK also con-
tributes to the formation of AP-1 by producing c-Jun
and c-Fos [52]. Moreover, JNK activation can induce the
phosphorylation of Elk-1 and promote subsequent tran-
scription activities. Interestingly, E2 activated JNK and
p38 MAPK pathways, but had no effect on the ERK
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of all three of these pathways were activated by E2. This
indicates that these downstream transcription factors
can not only be activated by their upstream kinases,
such as ERK, JNK and p38 MAPK, but can also be trig-
gered by ligand-bound ERs directly. Therefore, we specu-
late that E2 may play an important role during the crosstalk
between the ER and MAPK signaling pathways.
In this study, E2 can promote the odonto/osteogenic
differentiation of SCAP. Thus, E2 can be used to stimulate
the differentiation of SCAP in the apical papillae suffering
from pulp infections to recover the interrupted root devel-
opment. Moreover, when cultured with PDLSCs together
in vivo, they can form a biological root (bio-root) as previ-
ously reported [7]. Recent studies also reported that E2
can enhance the proliferation and differentiation of
PDLSCs [15]. Thus, when the two kinds of cells are co-
cultured with E2, they may generate a bio-root more
regularly and efficiently. However, tooth growth is a
complicated process that is affected by a series of factors,
including patients’ conditions, cell activity, growth factors
and so on. More work is required to make SCAP and E2
better applied in future clinical practice.
Conclusions
In conclusion, E2 enhanced the odonto/osteogenic dif-
ferentiation of SCAP via activation of the MAPK signal-
ing pathway. These findings provide a new insight into
the use of E2 for tooth engineering. More work has to
be performed to explore other potential mechanisms in-
volved in the differentiation of E2-treated SCAP, which
may help the application of E2 in future endodontic
practice.
Abbreviations
ADSCs: adipose tissue-derived stem cells; AGS: absorbable gelatin sponges;
ALP: alkaline phosphatase; AP-1: activating protein-1; BMMSCs: bone marrow
mesenchymal stem cells; CPC: cetylpyridinium chloride; DMP1: dentin matrix
protein 1; DMSO: dimethyl sulfoxide; DPSCs: dental pulp stem cells; DSP: dentin
sialoprotein; DSPP: dentin sialophosphoprotein; E2: 17beta-estradiol; ER: estrogen
receptor; ERE: estrogen response elements; ERK: extracellular signal-regulated
kinase; FBS: fetal bovine serum; FCM: flow cytometry; H & E: hematoxylin and
eosin; JNK: c-Jun N-terminal kinase; MAPK: mitogen-activated protein kinase;
MM: mineralization-inducing media; MSCs: mesenchymal stem cells;
MTT: methyl-thiazolyl-tetrazolium; OCN: osteocalcin; OSX: osterix;
PBS: hosphate-buffered solution; PDLSCs: periodontal ligament stem cells;
PFA: paraformaldehyde; RT-PCR: reverse transcription polymerase chain
reaction; RUNX2: runt-related transcription factor 2; SCAP: stem cells while
stem cells from apical papilla; α-MEM: alpha minimum essential medium.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YL made substantial contributions to the conception and design of the
study, carried out the study, performed the experiments and drafted the
manuscript. MY participated in the design of the study, collected all data,
performed data analysis and helped to draft the manuscript. ZLW performed
the immunofluorescence, immunocytochemical and immunohistochemical
staining and drafted the manuscript. YYZ contributed to the animal
experiments and helped to draft the manuscript. JJL was responsible for cellculture experiments and manuscript drafting. SM and GXL contributed to
mesenchymal stem cell isolation and expansion and helped to draft the
manuscript. JHY conceived the study, and contributed to study design and
coordination, analysis and interpretation of data, and manuscript revision.
All authors read and approved the final manuscript.
Acknowledgements
This work was supported by the National Natural Science Foundation of
China (No. 81371144), the Natural Science Foundation of Jiangsu Province
(No. BK20131392), and the Priority Academic Program Development of
Jiangsu Higher Education Institutions (PAPD, No. 2014–37).
Author details
1Department of Stomatology, Nanjing Integrated Traditional Chinese and
Western Medicine Hospital Affiliated with Nanjing University of Chinese
Medicine, Nanjing, Jiangsu 210014, China. 2Key Laboratory of Oral Diseases of
Jiangsu Province and Stomatological Institute of Nanjing Medical University,
140 Hanzhong Road, Nanjing, Jiangsu 210029, China. 3Endodontic
Department, School of Stomatology, Nanjing Medical University, 136
Hanzhong Road, Nanjing, Jiangsu 210029, China.
Received: 13 February 2014 Revised: 28 October 2014
Accepted: 29 October 2014 Published: 17 November 2014
References
1. Huang GT: A paradigm shift in endodontic management of immature
teeth: conservation of stem cells for regeneration. J Dent 2008, 36:379–386.
2. Huang GT, Sonoyama W, Liu Y, Liu H, Wang S, Shi S: The hidden treasure
in apical papilla: the potential role in pulp/dentin regeneration and
BioRoot engineering. J Endod 2008, 34:645–651.
3. Huang GT: Apexification: the beginning of its end. Int Endod J 2009,
42:855–866.
4. Sonoyama W, Liu Y, Yamaza T, Tuan RS, Wang S, Shi S, Huang GT:
Characterization of the apical papilla and its residing stem cells from
human immature permanent teeth: a pilot study. J Endod 2008,
34:166–171.
5. Sonoyama W, Liu Y, Fang D, Yamaza T, Seo BM, Zhang C, Liu H, Gronthos S,
Wang CY, Wang S, Shi S: Mesenchymal stem cell-mediated functional tooth
regeneration in swine. PLoS One 2006, 1:e79.
6. Abe S, Yamaguchi S, Watanabe A, Hamada K, Amagasa T: Hard tissue
regeneration capacity of apical pulp derived cells (APDCs) from human
tooth with immature apex. Biochem Biophys Res Commun 2008, 371:90–93.
7. Dadu SS: Tooth regeneration: current status. Indian J Dent Res 2009,
20:506–550.
8. Wang Y, Zheng Y, Wang Z, Li J, Zhang G, Yu J: 10(–7) m17β-oestradiol
enhances odonto/osteogenic potency of human dental pulp stem cells
by activation of the NF-κB pathway. Cell Prolif 2013, 46:677–684.
9. Bakopoulou A, Leyhausen G, Volk J, Koidis P, Geurtsen W: Comparative
characterization of STRO-1neg/CD146pos and STRO-1pos/CD146pos
apical papilla stem cells enriched with flow cytometry. Arch Oral Biol
2013, 58:1556–1568.
10. Ruparel NB, Teixeira FB, Ferraz CC, Diogenes A: Direct effect of intracanal
medicaments on survival of stem cells of the apical papilla. J Endod 2012,
38:1372–1375.
11. Jiang Q, Du J, Yin X, Shan Z, Ma Y, Ma P, Fan Z: Shh signaling, negatively
regulated by BMP signaling, inhibits the osteo/dentinogenic
differentiation potentials of mesenchymal stem cells from apical papilla.
Mol Cell Biochem 2013, 383:85–93.
12. Wang Y, Yan M, Yu Y, Wu J, Yu J, Fan Z: Estrogen deficiency inhibits the
odonto/osteogenic differentiation of dental pulp stem cells via
activation of the NF-κB pathway. Cell Tissue Res 2013, 352:551–559.
13. Xue P, Wang Y, Yang J, Li Y: Effects of growth hormone replacement
therapy on bone mineral density in growth hormone deficient adults: a
meta-analysis. Int J Endocrinol 2013, 2013:1–13.
14. Bin Zhang YL, Zhou Q, Ding Y: Estrogen deficiency leads to impaired
osteogenic differentiation of periodontal ligament stem cells in rats.
Tohoku J Exp Med 2011, 223:177–186.
15. Mamalis A, Markopoulou C, Lagou A, Vrotsos I: Oestrogen regulates
proliferation, osteoblastic differentiation, collagen synthesis and
periostin gene expression in human periodontal ligament cells through
oestrogen receptor beta. Arch Oral Biol 2011, 56:446–455.
Li et al. Stem Cell Research & Therapy 2014, 5:125 Page 12 of 12
http://stemcellres.com/content/5/6/12516. Zhang M, Chen FM, Wang AH, Chen YJ, Lv X, Wu S, Zhao RN: Estrogen and
its receptor enhance mechanobiological effects in compressed bone
mesenchymal stem cells. Cells Tissues Organs 2012, 195:400–413.
17. Zhao JW, Gao ZL, Mei H, Li YL, Wang Y: Differentiation of human
mesenchymal stem cells: the potential mechanism for estrogen-induced
preferential osteoblast versus adipocyte differentiation. Am J Med Sci
2011, 341:460–468.
18. Yu J, Wang Y, Deng Z, Tang L, Li Y, Shi J, Jin Y: Odontogenic capability:
bone marrow stromal stem cells versus dental pulp stem cells. Biol Cell
2007, 99:465–474.
19. Lei G, Yan M, Wang Z, Yu Y, Tang C, Yu J, Zhang G: Dentinogenic capacity:
immature root papilla stem cells versus mature root pulp stem cells.
Biol Cell 2011, 103:185–196.
20. Wang S, Mu J, Fan Z, Yu Y, Yan M, Lei G, Tang C, Wang Z, Zheng Y, Yu J,
Zhang G: Insulin-like growth factor 1 can promote the osteogenic
differentiation and osteogenesis of stem cells from apical papilla. Stem
Cell Res 2012, 8:346–356.
21. Yu J, He H, Tang C, Zhang G, Li Y, Wang R, Shi J, Jin Y: Differentiation potential
of STRO-1+ dental pulp stem cells changes during cell passaging. BMC Cell
Biol 2010, 11:32.
22. Galea GL, Price JS, Lanyon LE: Estrogen receptors’ roles in the control of
mechanically adaptive bone (re)modeling. Bonekey Rep 2013, 2:413.
23. Ozono S, Fujita T, Matsuo M, Todoki K, Ohtomo T, Negishi H, Kawase T:
Co-treatment with basic fibroblast growth factor and 17beta-estradiol in
the presence of dexamethasone accelerates bone formation by rat bone
marrow stromal cell culture. Nihon Hotetsu Shika Gakkai Zasshi 2008,
52:366–374.
24. Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N:
Effects of glucose and its modulation by insulin and estradiol on BMSC
differentiation into osteoblastic lineages. Biochem Cell Biol 2006, 84:93–101.
25. Hong L, Colpan A, Peptan IA: Modulations of 17-β estradiol on osteogenic
and adipogenic differentiations of human mesenchymal stem cells.
Tissue Eng 2006, 12:2747–2753.
26. Taskiran D, Evren V: Stimulatory effect of 17β-estradiol on osteogenic
differentiation potential of rat adipose tissue-derived stem cells.
Gen Physiol Biophys 2011, 30:167–174.
27. Liang L, Yu JF, Wang Y, Wang G, Ding Y: Effect of estrogen receptor beta
on the osteoblastic differentiation function of human periodontal
ligament cells. Arch Oral Biol 2008, 53:553–557.
28. Iejima D, Sumita Y, Kagami H, Ando Y, Ueda M: Odontoblast marker gene
expression is enhanced by a CC-chemokine family protein MIP-3α in
human mesenchymal stem cells. Arch Oral Biol 2007, 52:924–931.
29. Chen S, Gluhak-Heinrich J, Wang YH, Wu YM, Chuang HH, Chen L, Yuan GH,
Dong J, Gay I, MacDougall M: Runx2, osx, and dspp in tooth development.
J Dent Res 2009, 88:904–909.
30. Yamazaki H, Kunisada T, Miyamoto A, Tagaya H, Hayashi SI: Tooth-specific
expression conferred by the regulatory sequences of rat dentin
sialoprotein gene in transgenic mice. Biochem Biophys Res Commun 1999,
260:433–440.
31. Yamakoshi Y: Dentinogenesis and Dentin Sialophosphoprotein (DSPP).
J Oral Biosci 2009, 51:134.
32. Ye L, MacDougall M, Zhang S, Xie Y, Zhang J, Li Z, Lu Y, Mishina Y, Feng JQ:
Deletion of dentin matrix protein-1 leads to a partial failure of maturation
of predentin into dentin, hypomineralization, and expanded cavities of
pulp and root canal during postnatal tooth development. J Biol Chem 2004,
279:19141–19148.
33. Gibson MP, Zhu Q, Wang S, Liu Q, Liu Y, Wang X, Yuan B, Ruest LB, Feng
JQ, D'Souza RN, Qin C, Lu Y: The rescue of dentin matrix protein 1
(DMP1)-deficient tooth defects by the transgenic expression of dentin
sialophosphoprotein (DSPP) indicates that DSPP is a downstream
effector molecule of DMP1 in dentinogenesis. J Biol Chem 2013,
288:7204–7214.
34. Komori T: Regulation of osteoblast differentiation by Runx2. Adv Exp Med
Biol 2010, 658:43–49.
35. Ni P, Fu S, Fan M, Guo G, Shi S, Peng J, Luo F, Qian Z: Preparation of poly
(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue
engineering. Int J Nanomedicine 2011, 6:3065–3075.
36. Wade-Gueye NM, Boudiffa M, Vanden-Bossche A, Laroche N, Aubin JE, Vico L,
Lafage-Proust MH, Malaval L: Absence of bone sialoprotein (BSP) impairs
primary bone formation and resorption: the marrow ablation model
under PTH challenge. Bone 2012, 50:1064–1073.37. D'Souza RN, Aberg T, Gaikwad J, Cavender A, Owen M, Karsenty G, Thesleff I:
Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth
development in mice. Development 1999, 126:2911–2920.
38. Takahashi T: Overexpression of Runx2 and MKP-1 stimulates
transdifferentiation of 3 T3-L1 preadipocytes into bone-forming
osteoblasts in vitro. Calcif Tissue Int 2011, 88:336–347.
39. Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, de Crombrugghe B, Kim JE:
Positive regulation of adult bone formation by osteoblast-specific
transcription factor osterix. J Bone Miner Res 2009, 24:1055–1065.
40. Neugebauer BM, Moore MA, Broess M, Gerstenfeld LC, Hauschka PV:
Characterization of structural sequences in the chicken osteocalcin gene:
expression of osteocalcin by maturing osteoblasts and by hypertrophic
chondrocytes in vitro. J Bone Miner Res 1995, 10:157–163.
41. Qu Q, Perala-Heape M, Kapanen A, Dahllund J, Salo J, Vaananen HK, Harkonen P:
Estrogen enhances differentiation of osteoblasts in mouse bone marrow
culture. Bone 1998, 22:201–209.
42. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M,
Strom A, Treuter E, Warner M, Gustafsson JA: Estrogen receptors: how do
they signal and what are their targets. Physiol Rev 2007, 87:905–931.
43. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a
novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci
U S A 1996, 93:5925–5930.
44. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F,
Giguere V: Cloning, chromosomal localization, and functional analysis of
the murine estrogen receptor beta. Mol Endocrinol 1997, 11:353–365.
45. Santagati S, Gianazza E, Agrati P, Vegeto E, Patrone C, Pollio G, Maggi A:
Oligonucleotide squelching reveals the mechanism of estrogen receptor
autologous down-regulation. Mol Endocrinol 1997, 11:938–949.
46. Bodine PV, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB,
Komm BS: Estrogen receptor-alpha is developmentally regulated during
osteoblast differentiation and contributes to selective responsiveness of
gene expression. Endocrinology 1998, 139:2048–2057.
47. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC:
Kinase-mediated regulation of common transcription factors accounts
for the bone-protective effects of sex steroids. J Clin Invest 2003,
111:1651–1664.
48. Migliaccio A, Zhou C, Steplowski TA, Dickens HK, Malloy KM, Gehrig PA,
Boggess JF, Bae-Jump VL: Estrogen induction of telomerase activity
through regulation of the mitogen-activated protein kinase (MAPK)
dependent pathway in human endometrial cancer cells. PLoS One 2013,
8:e55730.
49. Derwahl M, Nicula D: Estrogen and its role in thyroid cancer. Endocr Relat
Cancer 2014, 21:T273–T283.
50. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E,
Pettersson K, Warner M, Gustafsson JA: Mechanisms of estrogen action.
Physiol Rev 2001, 81:1535–1565.
51. Moriarty K, Kim KH, Bender JR: Minireview: estrogen receptor-mediated
rapid signaling. Endocrinology 2006, 147:5557–5563.
52. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA,
Safe S: Ligand-, cell-, and estrogen receptor subtype (alpha /beta )-dependent
activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000,
275:5379–5387.
53. Babu RL, Naveen Kumar M, Patil RH, Devaraju KS, Ramesh GT, Sharma SC:
Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors
in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Mol Cell Biochem 2013, 380:143–151.
54. Xiao HH, Gao QG, Zhang Y, Wong KC, Dai Y, Yao XS, Wong MS: Vanillic acid
exerts oestrogen-like activities in osteoblast-like UMR 106 cells through
MAP kinase (MEK/ERK)-mediated ER signaling pathway. J Steroid Biochem
Mol Biol 2014, 144 Pt B:382–391.
55. Tang YQ, Jaganath I, Manikam R, Sekaran SD: Phyllanthus suppresses
prostate cancer cell, PC-3, proliferation and induces apoptosis through
multiple signalling pathways (MAPKs, PI3K/Akt, NFkappaB, and hypoxia).
Evid Based Compl Alternat Med 2013, 2013:609581.
doi:10.1186/scrt515
Cite this article as: Li et al.: 17beta-estradiol promotes the odonto/osteogenic
differentiation of stem cells from apical papilla via mitogen-activated protein
kinase pathway. Stem Cell Research & Therapy 2014 5:125.
